For retail sale medicaments with insulin or hormones or antibiotics market in Greece

Earlier Report Observations

The market for packed retail medicaments containing insulin or hormones in Greece showed notable shifts from 2018 to 2020. Market size fell from $171.9 million in 2018 to $142.3 million in 2019, then recovered to $164.2 million in 2020. This pattern mirrored import movements, which dropped to $168.7 million in 2019 before rising to $228.1 million in 2020, while exports increased sharply to $89.8 million that year.

In the following years through 2024, import values grew consistently, reaching $315.0 million by 2024. Exports also expanded markedly, surging to $181.7 million in 2024. This upward trajectory was underpinned by global drivers such as rising diabetes prevalence, demographic aging, and continuous innovation in insulin delivery devices including pens and pumps.

Production for retail sale medicaments with insulin or hormones or antibiotics in Greece

In value, 2017-2020, K $ US

In Greece, the production value of retail sale medicaments containing insulin, hormones, or antibiotics reached 25 827 thousand US dollars in 2020, marking an 18.0% year-over-year increase. From 2017 to 2020, production grew by 67.6%, which translates to an annualized rate of 18.8%. The largest decline occurred in 2019, with a drop of 4.9%, while the largest increase was recorded in 2018 at 49.3%.

Annual dynamics of production in Greece in value, 2017-2020, K $ US

Exports for retail sale medicaments with insulin or hormones or antibiotics from Greece

Exports in kind, t

The market exhibited volatility during this period. In 2019, exports hit their lowest point at 399 tonnes, with a decline of 34.1%. By 2020, cross-border shipments of retail sale medicaments containing insulin, hormones, or antibiotics from Greece surged to 724 tonnes, an 81.2% increase from the previous year, representing the peak. The difference between the peak in 2020 and the trough in 2019 was 1.8 times.

Annual dynamics of product's exports from Greece in kind, 2017-2020, t

From 2017 to 2020, France, Cyprus, and the United Kingdom were the top buyers of retail sale medicaments containing insulin, hormones, or antibiotics from Greece. France accounted for 31.2% of exports in kind, Cyprus for 22.5%, and the United Kingdom for 17.7%. Together, these three countries made up 71.4% of total exports in kind.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Greece in kind, 2017-2020

Exports in value, M $ US

The market demonstrated volatility over the observed years. In 2019, exports experienced the largest decline of 7.9%. By 2020, Greece's export value of retail sale medicaments containing insulin, hormones, or antibiotics rose to 89.8 million US dollars, an 85.7% gain compared to 2019. The peak-to-trough amplitude from 2017 to 2020 was 1.9 times.

Annual dynamics of product's exports from Greece in value, 2017-2020, M $ US

Between 2017 and 2020, the leading destinations for Greece's exports in value terms of retail sale medicaments containing insulin, hormones, or antibiotics were France, Cyprus, and Germany. France contributed 19.0% of exports in value terms, Cyprus 17.5%, and Germany 17.0%. Collectively, these three markets accounted for 53.5% of total export flows.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Greece in value, 2017-2020

Imports for retail sale medicaments with insulin or hormones or antibiotics to Greece

Imports in kind, t

In 2019, imports of retail sale medicaments containing insulin, hormones, or antibiotics into Greece reached their minimum at 1 366 tonnes, with a decline of 19.0%. By 2020, cross-border shipments increased to 1 972 tonnes, reflecting a sharp 44.3% year-over-year rise. From 2017 to 2020, imports grew by 32.7%, equating to an annualized rate of 9.9%.

Annual dynamics of product's imports to Greece in kind, 2017-2020, t

Throughout 2017 to 2020, Germany, France, and Italy were the key sources for imports in kind of retail sale medicaments containing insulin, hormones, or antibiotics into Greece. Germany represented 35.1% of imports in kind, France 25.3%, and Italy 12.7%. Together, these three countries accounted for 73.1% of total import flows.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Greece in kind, 2017-2020

Imports in value, M $ US

In 2019, Greece's import value of retail sale medicaments containing insulin, hormones, or antibiotics was at its lowest, at 168.7 million US dollars, with a decline of 16.2%. By 2020, imports rose to 228.1 million US dollars, showing a sudden 35.2% year-over-year increase. Over the period from 2017 to 2020, imports increased by 24.1%, with a compound annual growth rate of 7.5%.

Annual dynamics of product's imports to Greece in value, 2017-2020, M $ US

From 2017 to 2020, Germany, Denmark, and Italy were the main markets for Greece's imports in value terms of retail sale medicaments containing insulin, hormones, or antibiotics. Germany accounted for 28.2% of imports in value terms, Denmark for 19.8%, and Italy for 11.7%. In total, these three countries made up 59.7% of import flows.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Greece in value, 2017-2020